Hypogonadism as a risk factor for cardiovascular mortality in men: a meta-analytic study
The DOI matches its Crossref record; 139 of the 139 references it cites were found in a registry or an index.
Abstract
Objective: To verify whether hypogonadism represents a risk factor for cardiovascular (CV) morbidity and mortality and to verify whether testosterone replacement therapy (TRT) improves CV parameters in subjects with known CV diseases (CVDs). Design: Meta-analysis. Methods: An extensive Medline search was performed using the following words ‘testosterone, CVD, and males’. The search was restricted to data from January 1, 1969, up to January 1, 2011. Results: Of the 1178 retrieved articles, 70 were included in the study. Among cross-sectional studies, patients with CVD have significantly lower testosterone and higher 17-β estradiol (E 2 ) levels. Conversely, no difference was observed for DHEAS. The association between low testosterone and high E 2 levels with CVD was confirmed in a logistic regression model, after adjusting for age and body mass index (hazard ratio (HR)=0.763 (0.744–0.783) and HR=1.015 (1.014–1.017), respectively, for each increment of total testosterone and E 2 levels; both P <0.0001). Longitudinal studies showed that baseline testosterone level was significantly lower among patients with incident overall- and CV-related mortality, in comparison with controls. Conversely, we did not observe any difference in the baseline testosterone and E 2 levels between case and controls for incident CVD. Finally, TRT was positively associated with a significant increase in treadmill test duration and time to 1 mm ST segment depression. Conclusions: Lower testosterone and higher E 2 levels correlate with increased risk of CVD and CV mortality. TRT in hypogonadism moderates metabolic components associated with CV risk. Whether low testosterone is just an association with CV risk, or an actual cause–effect relationship, awaits further studies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Assessing the quality of reports of randomized clinical trials: Is blinding necessary?
Jadad, A. R., Moore, R. A., Carroll, D., Jenkinson, C., Reynolds, D. J. M., Gavaghan, D. J., & McQuay, H. J. (1996) · Controlled Clinical Trials · doi:10.1016/0197-2456(95)00134-4 · Cited by 17,582
The measurement of psychological androgyny
Bem, S. L. (1974) · Journal of Consulting and Clinical Psychology · doi:10.1037/h0036215 · Cited by 8,522
The Journal of Family Practice
(1997) · The American Journal of Family Therapy · doi:10.1080/01926189708251066 · Cited by 3,067
Bhasin, S., Cunningham, G. R., Hayes, F. J., Matsumoto, A. M., Snyder, P. J., Swerdloff, R. S., & Montori, V. M. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2354 · Cited by 1,954
Adverse Events Associated with Testosterone Administration
Basaria, S., Coviello, A. D., Travison, T. G., Storer, T. W., Farwell, W. R., Jette, A. M., Eder, R., Tennstedt, S., Ulloor, J., Zhang, A., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1000485 · Cited by 1,494
Friedman, M. (1959) · Journal of the American Medical Association · doi:10.1001/jama.1959.03000290012005 · Cited by 1,485
Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer
Keating, N. L., O'Malley, A. J., & Smith, M. R. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.2497 · Cited by 1,455
Ding, E. L., Song, Y., Malik, V. S., & Liu, S. (2006) · JAMA · doi:10.1001/jama.295.11.1288 · Cited by 1,354
Indian Journal of Physiology and Pharmacology
(2020) · Indian Journal of Physiology and Pharmacology · doi:10.25259/ijpp · Cited by 1,030
Association between premature mortality and hypopituitarism
Tomlinson, J., Holden, N., Hills, R., Wheatley, K., Clayton, R., Bates, A., Sheppard, M., & Stewart, P. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04006-x · Cited by 1,006
Research works printed but not linked: 22
- 1978, JAMA, 107, 362
- 2010, Heart, 97, 870
- 1980, 35, 123
- 1983, 48, 235
- 1986, 59, 37
- 1987, 67, 155
- SMALL, 1987, QJM, 64, 617
- 1989, 79, 197
- 1990, 83, 111
- Dash, 1991, Functional neurology, 6, 29
- 1994, 105, 191
- 1997, 62, 789
- 2000, JOURNAL OF THE MEDICAL ASSOCIATION OF THAILAND, 83, 266
- 2003, JOURNAL OF MEDICAL INVESTIGATION, 50, 162
- 2003, MEDICAL SCIENCE MONITOR INTERNATIONAL MEDICAL JOURNAL OF EXPERIMENTAL AND CLINICAL RESEARCH, 9, 162CR
- 2007, CARDIOVASCULAR JOURNAL OF AFRICA, 18, 362
- Mohamad, 2007, Neuro endocrinology letters, 28, 182
- 2008, INTERNATIONAL ANGIOLOGY A JOURNAL OF THE INTERNATIONAL UNION OF ANGIOLOGY, 27, 135
- Corona, 2011, Journal of endocrinological investigation, 34, 557
- 2010, New England Journal of Medicine, 36, 3109
- 1999, Aging, 11, 30
- 2000, Aging, 12, 308
Cited by
Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline.
Bhasin, S., Brito, J. P., Cunningham, G. R., Hayes, F. J., Hodis, H. N., Matsumoto, A. M., Snyder, P. J., Swerdloff, R. S., Wu, F. C., & Yialamas, M. A. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00229 · Cited by 1,736
Shamloul, R., & Ghanem, H. (2013) · The Lancet · doi:10.1016/s0140-6736(12)60520-0 · Cited by 1,091
Increased Risk of Non-Fatal Myocardial Infarction Following Testosterone Therapy Prescription in Men
Finkle, W. D., Greenland, S., Ridgeway, G. K., Adams, J. L., Frasco, M. A., Cook, M. B., Fraumeni, J. F., & Hoover, R. N. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085805 · Cited by 735
Endogenous Testosterone and Mortality in Men: A Systematic Review and Meta-Analysis
Araujo, A. B., Dixon, J. M., Suarez, E. A., Murad, M. H., Guey, L. T., & Wittert, G. A. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1137 · Cited by 671
Xu, L., Freeman, G., Cowling, B. J., & Schooling, C. M. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-108 · Cited by 563
“We did not find any additional such trials from a bibliographic search of these 32 papers or from eight reviews [27-34].”
Metadata
- Authors
- Corona, G., Rastrelli, G., Monami, M., Guay, A., Buvat, J., Sforza, A., Forti, G., Mannucci, E., & Maggi, M.
- Affiliations
- Azienda USL di Bologna (IT)
- University of Florence (IT)
- Lahey Hospital and Medical Center (US)
- Corresponding author
- Maggi, Mario
- Venue
- European Journal of Endocrinology
- Publisher
- Oxford University Press (OUP)
- Published
- 2011-11
- Volume
- 165
- Issue
- 5
- Pages
- 687-701
- ISSN
- 0804-4643 (ISSN-L)
- 1479-683X
- OpenAlex
- W2160915817
- Semantic Scholar
- 92bb83280a07cce997db70a4ca880964577f45fe
- Cited by
- 435
- References
- 138
- Citations by year
- 2026: 9 · 2025: 24 · 2024: 15 · 2023: 19 · 2022: 31 · 2021: 21 · 2020: 29 · 2019: 25 · 2018: 27 · 2017: 42 · 2016: 24 · 2015: 34 · 2014: 55 · 2013: 50 · 2012: 25
- FWCI
- 5.98
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- European Journal of Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Keywords
- hypogonadism, cardiovascular mortality, cardiovascular disease, testosterone, testosterone replacement therapy, estradiol, dehydroepiandrosterone sulfate, men, cardiovascular risk factors, treadmill exercise capacity, ST-segment depression
- MeSH terms
- Animals, Cardiovascular Diseases, Estradiol, Humans, Hypogonadism, Male, Risk Factors, Testosterone, Randomized Controlled Trials as Topic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Hypogonadism as a risk factor for cardiovascular mortality in men: a meta-analytic study. https://app.cochat.ai/papers/10.1530/eje-11-0447
- The paper
- Corona, G., Rastrelli, G., Monami, M., Guay, A., Buvat, J., Sforza, A., Forti, G., Mannucci, E., & Maggi, M. (2011). Hypogonadism as a risk factor for cardiovascular mortality in men: a meta-analytic study. European Journal of Endocrinology. https://doi.org/10.1530/eje-11-0447
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.